Sunday - December 14, 2025

Alcohol Use Disorder Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Alcohol Use Disorder Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the Alcohol Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Duchenne Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading